Comparing two ways to get hepatitis C treatment in Cameroon
Part of Digestive system, Infections clinical trials.
This trial compares a simplified way of testing and treating hepatitis C with the standard approach. It aims to see if the simpler method works just as well and makes it easier for people to get treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 21 years old or older.
- You must have tested positive for hepatitis C (anti-HCV positive).
- You must live in the study area in Cameroon.
- You must agree to join the trial and sign a consent form.
- You cannot have been treated for hepatitis C before with a drug called sofosbuvir.
- You cannot have hepatitis B (HBsAg positive) or be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study focuses on screening, treating, and eliminating hepatitis C. It is for people who may be at risk or newly diagnosed, and aims to connect them with care that could help clear the virus.
This study tests a simple treatment for Hepatitis C in people experiencing unsheltered homelessness. It aims to help those who are receiving street medicine care and have not been treated before.
This study compares two ways to treat hepatitis C: getting treatment at a local clinic near you, or the usual care at a central hospital. It aims to see if treatment at local clinics is safe, effective, and more convenient for patients.
This trial looks at hepatitis C treatment for people whose last antiviral medicines did not fully clear the virus. It may help by testing a study drug approach for people in Pakistan who still have active hepatitis C infection.
This study tests a pill combination (sofosbuvir/velpatasvir) to cure hepatitis C. It aims to make treatment simple and accessible, and you can join even if you've had treatment before (if it failed or you got reinfected).
This study looks at how to make hepatitis C testing and treatment easier to access in Canada. It involves different people, like those at risk, healthcare workers, and policy makers, to find better ways to offer care.
Hear when a new Hepatitis C Virus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.